---

Abortifacient Morning After Pill Without Prescription a Canadian Election Issue

Launch your concerns now, say pro-life leaders

OTTAWA, May 26, 2004 (LifeSiteNews.com) - The official contact information for Canadians wanting to voice concerns over Health Canada's proposal to allow the abortion-causing morning after pill to be available without a doctor's prescription has been released. On Saturday, Canada Gazette I released the information and pro-life leaders have urged all concerned Canadians to demand that the dangerous drugs be curtailed rather than promoted.

Rhonda Wood, spokesman for Campaign Life Coalition told LifeSiteNews.com that the matter is an election issue. The issue was raised on a Campaign Life questionnaire that went out to all candidates in the federal election. Wood said, "Since Health Canada is an arm of the federal government and it has initiated this change in regulations over the election period, the government should expect it to become an election issue."

While pro-life Canadians are concerned about the drugs since they can cause the death of already conceived unborn children, many health care practitioners are concerned about the proposal to give the drug non-prescription status for other reasons. Health concerns for the women and girls who were to use the drugs were the primary motivation behind the US Food and Drug Administration's rejection of over the counter status.

All those concerned are urged to contact:
Karen Ash,
Policy Division, Bureau of Policy,
Therapeutic Products Directorate,
Department of Health,
1600 Scott Street, Holland Cross, Tower B, 2nd Floor,
Ottawa, Ontario K1A 0K9
(613) 957-6455;
fax: (613) 941-6458;
e-mail:

Note: All those making representations must cite the Canada Gazette, Part I (May 22, 2004 issue), and the date of publication of the notice May 11, 2004 and refer to the proposal to make the annexed Regulations Amending the Food and Drug Regulations (1272 - Levonorgestrel).

See the Canada Gazette I on the issue;
http://canadagazette.gc.ca/partI/2004/20040522/html/regle1-e.html

 Back to Top

---

MORE NEWS: LifeSiteNews.com Home Page  Last 10 Days   Archives   Special Reports

Copyright © LifeSiteNews.com. This work is licensed under a Creative Commons Attribution-No Derivatives License. You may republish this article or portions of it without request provided the content is not altered and it is clearly attributed to "LifeSiteNews.com". Any website publishing of complete or large portions of original LifeSiteNews articles MUST additionally include a live link to www.LifeSiteNews.com. The link is not required for excerpts. Republishing of articles on LifeSiteNews.com from other sources as noted is subject to the conditions of those sources.